Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nervous system lupus: pathogenesis and rationale for therapy

J A Denburg1, S D Denburg, R M Carbotte

  • 1Department of Medicine, McMaster University, Hamilton, Ontario, Canada.

Scandinavian Journal of Rheumatology
|January 1, 1995
PubMed
Summary

Central nervous system (CNS) lupus involves multiple pathogenic mechanisms, including autoantibodies and inflammation. Research highlights therapeutic interventions targeting these pathways for improved patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Toll-like receptor-induced expression of epithelial cytokine receptors on haemopoietic progenitors is altered in allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2017
Same author

Erratum to: Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2017
Same author

ARIA 2016: Care pathways implementing emerging technologies for predictive medicine in rhinitis and asthma across the life cycle.

Clinical and translational allergy·2017
Same author

Scaling up strategies of the chronic respiratory disease programme of the European Innovation Partnership on Active and Healthy Ageing (Action Plan B3: Area 5).

Clinical and translational allergy·2016
Same author

Prenatal and early-life predictors of atopy and allergic disease in Canadian children: results of the Family Atherosclerosis Monitoring In earLY life (FAMILY) Study.

Journal of developmental origins of health and disease·2016
Same author

T regulatory cell phenotypes in peripheral blood and bronchoalveolar lavage from non-asthmatic and asthmatic subjects.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology·2015

Area of Science:

  • Neuroimmunology
  • Rheumatology

Background:

  • Central nervous system (CNS) lupus involves diverse pathogenic mechanisms.
  • These include autoantibody-mediated damage, immune complex deposition, vasculitis, microthrombosis, and cytokine-induced inflammation.
  • Aberrant MHC Class II expression and T-cell responses, similar to multiple sclerosis models, also contribute.

Purpose of the Study:

  • To review and synthesize current understanding of CNS lupus pathogenesis.
  • To highlight recent findings on therapeutic interventions in animal models and human studies.
  • To establish a rationale for treatment based on presumed pathogenic mechanisms.

Main Methods:

  • Review of in vitro and in vivo studies on CNS lupus.
  • Analysis of autoantibody specificities and their association with neurological symptoms.

Related Experiment Videos

  • Evaluation of therapeutic effects of corticosteroids, immunosuppressants, and anticoagulants.

    • Main Results:

    • Multiple distinct pathogenic pathways contribute to CNS lupus.
    • Specific autoantibodies correlate with cognitive dysfunction and neurological manifestations.
    • Early lymphoid brain infiltration in MRL/lpr mice is linked to neurobehavioral dysfunction.
    • Therapeutic interventions show promise in managing clinical and subclinical disease.

    Conclusions:

    • CNS lupus pathogenesis is multifactorial, requiring tailored treatment strategies.
    • Understanding specific mechanisms can guide the selection of therapies like corticosteroids, immunosuppressants, or anticoagulants.
    • Further research integrating pathogenetic insights with clinical outcomes is crucial for optimizing CNS lupus management.